
Sign up to save your podcasts
Or


We discuss the promising phase I results of the Helios trial studying AXPAXLI TKI inhibitor implant for diabetic retinopathy with Dr. Dilsher Dhoot of California Retina Consultants.
By Retina Synthesis4.5
88 ratings
We discuss the promising phase I results of the Helios trial studying AXPAXLI TKI inhibitor implant for diabetic retinopathy with Dr. Dilsher Dhoot of California Retina Consultants.

43 Listeners

18 Listeners

100 Listeners

113,121 Listeners

56,944 Listeners

5 Listeners

9,556 Listeners

11 Listeners

47,718 Listeners

51 Listeners

11 Listeners

470 Listeners

19 Listeners

0 Listeners